Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?

Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?

Wall Street analysts are divided in their predictions for Stryker stock's future performance. The Michigan-based medical technology company, with a market cap of $127.1 billion, has underperformed relative to the broader market, declining 12.8% compared to the S&P 500's 20.2% gain. While analysts maintain a strong buy consensus, concerns over slowing organic growth and softer sales momentum have weighed on the stock.

Despite a 9.4% revenue increase in Q2 and a 5.8% earnings beat, many analysts believe Stryker's top line remains a warning sign of potential demand slowdown. However, recent positive developments, such as a $100 million contract modification for Stryker Sales unit from the U.S. Defense Logistics Agency, have provided investors with a boost.

Analysts expect Stryker's EPS to grow 10.2% to $15.02 for the fiscal year 2026, with a price target averaging $379.81, representing a 11.7% premium to the current stock price.

Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at finance.yahoo.com →

More in Finance & Markets

More from Thursday 20 August →